pneumococcal vaccines
effectiveness results
impact of influenza
guide vaccination strategies
cases of influenza
low VE
specific VE
VI of vaccination programmes
vaccine types
EU countries
pneumococcal disease
cost benefit
Cost effectiveness analysis
Integrated Monitoring of Vaccines Effects
best methods
EU member state collaboration
Public Health Institutes
vaccine strain selection
robust benefit indicators
laboratory networks
overall effect
direct effect
current public health achievements
validated methods
post marketing vaccine performances
elderly population
best study
sustainable platform of primary care practices
hospitals
European Union
subtypes
schedules
duration of protection
occurrence of serotype replacement
role of repeated vaccinations
questions
serotypes
pneumococcus
committees
Consortium
SME
doses
interaction
real time basis
large sample sizes
studies
Universities
decision
factors
brands
expertise
boosters
pilot test
clinical outcomes
objectives
goal
international partners
measuring
country